Matthew Porteus
Keine laufenden Positionen mehr
Vermögen: 8 Mio $ am 30.04.2024
Aktive Positionen von Matthew Porteus
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| Stanford School of Medicine | Corporate Officer/Principal | 01.10.2010 | - |
| Stanford University | Corporate Officer/Principal | - | - |
Karriereverlauf von Matthew Porteus
Ehemalige bekannte Positionen von Matthew Porteus
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| The University of Texas Southwestern Medical Center | Corporate Officer/Principal | 01.02.2003 | 01.08.2010 |
| LENZ THERAPEUTICS, INC. | Direktor/Vorstandsmitglied | 01.03.2020 | - |
| Gründer | 01.06.2017 | - | |
| CRISPR THERAPEUTICS AG | Gründer | 31.10.2013 | - |
Ausbildung von Matthew Porteus
| Harvard University | Undergraduate Degree |
| Stanford University | Doctorate Degree |
Statistik
International
| Vereinigte Staaten | 6 |
| Schweiz | 2 |
Operativ
| Founder | 3 |
| Corporate Officer/Principal | 3 |
| Director/Board Member | 1 |
Sektoral
| Consumer Services | 5 |
| Health Technology | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| CRISPR THERAPEUTICS AG | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Graphite Bio, Inc.
 Graphite Bio, Inc. BiotechnologyHealth Technology Graphite Bio, Inc. is a clinical-stage gene editing company. It engages in the business of developing therapies that harness targeted gene integration to treat or cure serious diseases. The company was founded by Matthew Porteus and Maria Grazia Roncarolo on June 1, 2017 and is headquartered in South San Francisco, CA. | Health Technology |
- Börse
- Insiders
- Matthew Porteus
- Erfahrung
